Phase 1Recruiting

Tracing the Metabolic Flux of Orally Administered NAD+ Precursors

Tracing the Metabolic Flux of Orally Administered NAD+ Precursors in Healthy Young and Older Adults

Sponsor
Metro International Biotech, LLC (Industry)
Enrolment
32 planned
Conditions
Healthy Adults
Interventions
Nicotinamide Mononucleotide (NMN); Nicotinamide (NAM)
Ages
adults, older adults
Registry
NCT06882096

From the registry

We are doing this research to learn how healthy younger and older adults use two forms of vitamin B3-called nicotinamide mononucleotide (NMN) and nicotinamide (NAM)-to make NAD+. NAD+ is a natural substance that cells need for energy and other important processes. Our goal is to find out how these NAD precursors are absorbed and metabolized and how they raise NAD+ in different tissues. Who can join? Healthy adults men and women aged 18 to 40 (younger group) or 65 and older (older group) Participants with a body mass index ranging between 19 and 35 No major health issues like diabetes or severe kidney disease What will happen? Participants will take labeled or unlabeled NMN or NAM by mouth every day for 14 days. Researchers will collect blood, urine, and stool samples. Researchers also do a small muscle biopsy (under local numbing) twice to check how these NAD precursors raise NAD+ in muscle. Why is this important? NAD+ levels may drop as people age, and this drop could affect overall health and energy in cells. A better understanding of how NMN and NAM are metabolized in the…

Primary outcomes

  • Labelled NAD+ in Peripheral Blood
Full record on ClinicalTrials.gov